I anticipate a partnership for rivo-cel soon for BLCM The thrive study ongoing is a market opportunity for adults in transplant worth $3 to $4 billion.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.